FRESENIUS MEDICAL CARE AG Purchase Of Intangible Assets Classified As Investing Activities
FRESENIUS MEDICAL CARE AG (FMS) reported Purchase Of Intangible Assets Classified As Investing Activities of EUR 4.67 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG purchase of intangible assets classified as investing activities for the quarter ending 2019-12-31 was -11.88M EUR, a 187.30% decline year-over-year.
- FRESENIUS MEDICAL CARE AG purchase of intangible assets classified as investing activities for the quarter ending 2019-09-30 was 74.01M EUR, a 34.08% decline year-over-year.
- FRESENIUS MEDICAL CARE AG purchase of intangible assets classified as investing activities for the quarter ending 2019-06-30 was -15.62M EUR.
- FRESENIUS MEDICAL CARE AG purchase of intangible assets classified as investing activities for the quarter ending 2019-03-31 was -8.54M EUR.
| Period end | Purchase Of Intangible Assets Classified As Investing Activities 3 month | Purchase Of Intangible Assets Classified As Investing Activities 6 month | Purchase Of Intangible Assets Classified As Investing Activities 9 month | Purchase Of Intangible Assets Classified As Investing Activities 9 month as first filed | Purchase Of Intangible Assets Classified As Investing Activities 12 month | Purchase Of Intangible Assets Classified As Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | 4.67M EUR 20-F · filed 2026-02-24 | |||||
| 2024-12-31 | 8.54M EUR 20-F · filed 2026-02-24 | |||||
| 2023-12-31 | 26.37M EUR 20-F · filed 2026-02-24 | |||||
| 2022-12-31 | 46.35M EUR 20-F · filed 2025-02-25 | |||||
| 2021-12-31 | 32.35M EUR 20-F · filed 2024-02-20 | |||||
| 2020-12-31 | 33.25M EUR 20-F · filed 2023-02-22 | |||||
| 2019-12-31 | -11.88M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-02-22 | 62.13M EUR derived: sum of 2 quarters · filed 2022-02-22 | 46.52M EUR derived: sum of 3 quarters · filed 2022-02-22 | 37.97M EUR 20-F · filed 2022-02-22 | ||
| 2019-09-30 | 74.01M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 58.40M EUR derived: sum of 2 quarters · filed 2019-10-31 | 49.85M EUR 6-K · filed 2019-10-31 | 63.46M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | -15.62M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -24.16M EUR 6-K · filed 2019-07-30 | -10.55M EUR derived: sum of 3 quarters · filed 2021-02-23 | 101.73M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | -8.54M EUR 6-K · filed 2019-05-02 | 5.07M EUR derived: sum of 2 quarters · filed 2021-02-23 | 117.35M EUR derived: sum of 3 quarters · filed 2021-02-23 | 80.76M EUR derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | 13.61M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-02-23 | 125.90M EUR derived: sum of 2 quarters · filed 2021-02-23 | 89.30M EUR derived: sum of 3 quarters · filed 2021-02-23 | 85.10M EUR 20-F · filed 2021-02-23 | -85.10M EUR 20-F · filed 2019-02-20 | |
| 2018-09-30 | 112.29M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-10-31 | 75.69M EUR derived: sum of 2 quarters · filed 2019-10-31 | 71.49M EUR 6-K · filed 2019-10-31 | -71.49M EUR 6-K · filed 2018-10-30 | 113.55M EUR derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-06-30 | -36.59M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -40.79M EUR 6-K · filed 2019-07-30 | 1.26M EUR derived: sum of 3 quarters · filed 2020-02-20 | -7.06M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2018-03-31 | -4.20M EUR 6-K · filed 2019-05-02 | 37.85M EUR derived: sum of 2 quarters · filed 2020-02-20 | 29.54M EUR derived: sum of 3 quarters · filed 2020-02-20 | 26.16M EUR derived: sum of 4 quarters · filed 2020-02-20 | ||
| 2017-12-31 | 42.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-02-20 | 33.74M EUR derived: sum of 2 quarters · filed 2020-02-20 | 30.36M EUR derived: sum of 3 quarters · filed 2020-02-20 | 26.37M EUR 20-F · filed 2020-02-20 | ||
| 2017-09-30 | -8.31M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-10-30 | -11.69M EUR derived: sum of 2 quarters · filed 2018-10-30 | -15.68M EUR 6-K · filed 2018-10-30 | |||
| 2017-06-30 | -3.38M EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-01 | -7.37M EUR 6-K · filed 2018-08-01 | ||||
| 2017-03-31 | -3.99M EUR 6-K · filed 2018-05-03 | |||||
| 2016-12-31 | -12.17M EUR 20-F · filed 2019-02-20 | 12.17M EUR 20-F · filed 2018-02-27 | ||||
| 2015-12-31 | 29.34M EUR 20-F · filed 2018-02-27 |